1-Piperidinecarboxylic acid, 4-((4-((((2-(1-methylethyl)-1H-benzimidazol-7-yl)carbonyl)amino)methyl)-1-piperidinyl)methyl)-, methyl ester
Felcisetrag is a serotonin (5-HT) type 4 receptor agonist with potential gastrointestinal (GI) prokinetic activity. Upon administration, felcisetrag targets and binds to 5-HT4, thereby enhancing its activity. This may enhance GI motility, decrease GI tract and colonic transit time and improve constipation.